**
Introduction to Elaxim 40 Injection
**Elaxim 40 Injection is a prescription medication produced by Gennova Biopharmaceuticals Ltd. It contains the active ingredient Tenecteplase, with a concentration of 40mg per vial. This medication belongs to the therapeutic class of CARDIAC drugs, specifically categorized as Plasminogen Activators-Thrombolytics. As it is a prescription medicine, Elaxim 40 Injection should only be administered under the supervision of a healthcare professional.
**
Uses of Elaxim 40 Injection
**Elaxim 40 Injection is primarily used in the treatment of heart attacks. It works by breaking down blood clots, thereby restoring blood flow to the heart muscle. This medication is a crucial intervention during a heart attack to help minimize heart muscle damage and improve patient outcomes.
**
Price of Elaxim 40 Injection
**The Maximum Retail Price (MRP) of Elaxim 40 Injection is ₹43900 per vial. The cost may vary depending on the location and availability.
**
Dosage of Elaxim 40 Injection
**The dosage of Elaxim 40 Injection is determined by the healthcare provider based on the patient’s medical condition and response to treatment. It is usually administered as a single injection of the entire contents of one vial.
**
Benefits of Elaxim 40 Injection
**The primary benefit of Elaxim 40 Injection is its ability to rapidly dissolve blood clots, particularly in the setting of a heart attack. By restoring blood flow to the affected area, this medication can help prevent further damage to the heart muscle and potentially save lives.
**
Side Effects of Elaxim 40 Injection
**Like all medications, Elaxim 40 Injection may cause side effects in some individuals. Common side effects associated with this medication include:
– Injection site bleeding
– Nosebleeds
– Blood in stool
– Blood in urine
– Gastrointestinal bleeding
It is important to inform your healthcare provider if you experience any unexpected or persistent side effects while using Elaxim 40 Injection.
**
Active Ingredients in Elaxim 40 Injection
**The active ingredient in Elaxim 40 Injection is Tenecteplase, which acts as a thrombolytic agent to dissolve blood clots. Tenecteplase is a recombinant form of tissue plasminogen activator, specifically modified for enhanced clot-dissolving properties.
**
Pharmacological Properties of Elaxim 40 Injection
**Elaxim 40 Injection exerts its pharmacological effects by promoting the conversion of plasminogen to plasmin, an enzyme that breaks down fibrin clots. This mechanism of action helps to restore blood flow in occluded blood vessels, particularly in the context of acute myocardial infarction.
**
Indications for Elaxim 40 Injection
**Elaxim 40 Injection is indicated for the management of acute myocardial infarction (heart attack) to restore coronary artery patency. It is crucial for patients presenting with signs and symptoms of a heart attack to receive prompt treatment with Elaxim 40 Injection to improve outcomes.
**
Contraindications of Elaxim 40 Injection
**Elaxim 40 Injection is contraindicated in individuals with a history of hypersensitivity to tenecteplase or any component of the formulation. It should not be administered to patients with active internal bleeding, recent trauma, or known bleeding disorders.
**
Drug Interactions with Elaxim 40 Injection
**Elaxim 40 Injection may interact with other medications, including anticoagulants, antiplatelet agents, and thrombolytics. It is essential to inform your healthcare provider about all the medications you are currently taking to prevent potential drug interactions.
**
Patient Counseling for Elaxim 40 Injection
**Patients receiving Elaxim 40 Injection should be counseled on the following:
– The importance of timely administration of the medication during a heart attack
– Possible side effects and when to seek medical attention
– The need for regular follow-up with healthcare providers post-treatment
– Avoiding self-administration and the significance of healthcare supervision
**
Clinical Evidence and Studies on Elaxim 40 Injection
**Numerous clinical trials and studies have demonstrated the efficacy and safety of Tenecteplase, the active ingredient in Elaxim 40 Injection, in the treatment of acute myocardial infarction. These studies have shown significant improvements in outcomes for patients receiving this thrombolytic therapy.
**
Frequently Asked Questions (FAQs) About Elaxim 40 Injection
****Q: Is Elaxim 40 Injection habit-forming?**
A: No, Elaxim 40 Injection is not habit-forming as it is a thrombolytic agent used for acute medical conditions.
**Q: Can I self-administer Elaxim 40 Injection at home?**
A: No, Elaxim 40 Injection should only be administered by healthcare professionals in a clinical setting due to its potent thrombolytic effects.
**Q: Are there any dietary restrictions while taking Elaxim 40 Injection?**
A: Specific dietary restrictions are not typically required while using Elaxim 40 Injection. However, it is essential to follow a heart-healthy diet as advised by your healthcare provider.
**Q: How quickly should I seek medical help in case of a suspected heart attack?**
A: It is crucial to seek immediate medical attention if you experience symptoms of a heart attack, such as chest pain, shortness of breath, or nausea. Time is of the essence in maximizing the effectiveness of treatments like Elaxim 40 Injection.
**Q: Can Elaxim 40 Injection be used in pediatric patients?**
A: The use of Elaxim 40 Injection in pediatric patients should be determined by a pediatric cardiologist or healthcare provider experienced in treating children with cardiovascular conditions.
**
Conclusion
**In conclusion, Elaxim 40 Injection is a vital thrombolytic medication used in the management of acute myocardial infarction to restore coronary artery patency and improve patient outcomes. This prescription medicine contains the active ingredient Tenecteplase and should be administered under medical supervision. Understanding the uses, dosage, benefits, side effects, and other essential information about Elaxim 40 Injection is crucial for both healthcare providers and patients to ensure safe and effective treatment. If you have any further questions or concerns about Elaxim 40 Injection, consult your healthcare provider for personalized guidance.
MRP:
₹43900
Manufacturer:
Gennova Biopharmaceuticals Ltd
Salt:
Tenecteplase (40mg),
How to UseElaxim 40 Injection:
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Side Effects of Elaxim 40 Injection:
Injection site bleeding,Nosebleeds,Blood in stool,Blood in urine,Gastrointestinal bleeding,
Alternate Medicines for Elaxim 40 Injection:
Velix 40mg Injection,Metalyse 40mg Injection,
Prescription Required Status:
Prescription Required
Type of Selection:
1 Injection in 1 vial
Chemical Class:
Carboxylic Acids Derivatives
Habit Forming:
No
Therapeutic Class:
CARDIAC
Action Class:
Plasminogen Activators- Thrombolytics
. Please note, this information is for educational purposes only and not intended as medical advice.
